Using peripheral blood of treatment-naive, stable RRMS patients, CD4+NKG2D+ T cells produced significantly higher levels of IFN-γ and IL-17 upon stimulation when compared with cells from healthy controls (Figure 1I). This evidence concerns the gene IL17A and relapsing-remitting multiple sclerosis.